These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 144056)

  • 21. [Role of chronic HBsAg carriers in intrafamilial diffusion of hepatitis B virus infection].
    Pastore G; Dentico P; Angarano G; Pesce V; Schiraldi O
    Boll Ist Sieroter Milan; 1978 May; 57(2):197-203. PubMed ID: 728268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatitis B (HBV) and C (HBC) virus infections in Down's syndrome and in neuropsychiatric patients without Down's syndrome].
    Findor JA; Sordá JA; Rey J; Fernández J; Kohan A; Díaz Lestrem M
    G E N; 1992; 46(3):208-12. PubMed ID: 1340826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of asymptomatic HBeAG carrier state in a patient with Down's syndrome following human bite.
    Kanda T; Hara H; Hanaoka T; Kobayashi I
    J Med; 1994; 25(6):383-7. PubMed ID: 7769376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for celiac disease in Down's syndrome patients revealed cases of subtotal villous atrophy without typical for celiac disease HLA-DQ and tissue transglutaminase antibodies.
    Uibo O; Teesalu K; Metskula K; Reimand T; Saat R; Sillat T; Reimand K; Talvik T; Uibo R
    World J Gastroenterol; 2006 Mar; 12(9):1430-4. PubMed ID: 16552815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of hepatitis B virus among family members in the Middle East.
    Toukan AU; Sharaiha ZK; Abu-el-Rub OA; Hmoud MK; Dahbour SS; Abu-Hassan H; Yacoub SM; Hadler SC; Margolis HS; Coleman PJ
    Am J Epidemiol; 1990 Aug; 132(2):220-32. PubMed ID: 2372003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A seroepidemiological study of the prevalence of hepatitis B infections in a hyperendemic New Zealand community.
    Milne A; Allwood GK; Moyes CD; Pearce NE; Newell K
    Int J Epidemiol; 1987 Mar; 16(1):84-90. PubMed ID: 3570626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiology of hepatitis B in a residential institution for the mentally retarded.
    Boughton CR; Hawkes RA; Schroeter DR; Harlor JA
    Aust N Z J Med; 1976 Dec; 6(6):521-9. PubMed ID: 139881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antibody response of institutionalized Down's syndrome patients to seven microbial antigens.
    Hawkes RA; Boughton CR; Schroeter DR
    Clin Exp Immunol; 1978 Feb; 31(2):298-304. PubMed ID: 148342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic parameters in Down's syndrome.
    Jacobs PF; Burdash NM; Manos JP; Duncan RC
    Ann Clin Lab Sci; 1978; 8(1):17-22. PubMed ID: 146453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risks and prevention of severe RS virus infection among children with immunodeficiency and Down's syndrome.
    Mori M; Morio T; Ito S; Morimoto A; Ota S; Mizuta K; Iwata T; Hara T; Saji T
    J Infect Chemother; 2014 Aug; 20(8):455-9. PubMed ID: 24929631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B infection in institutionalized Down's syndrome inmates: a longitudinal study with five hepatitis B virus markers.
    Hawkes RA; Boughton CR; Schroeter DR; Decker RH; Overby LR
    Clin Exp Immunol; 1980 Jun; 40(3):478-86. PubMed ID: 6448112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological studies of patients with Down's syndrome. Measurements of autoantibodies and serum antibodies to dietary antigens in relation to zinc levels.
    Kanavin O; Scott H; Fausa O; Ek J; Gaarder PI; Brandtzaeg P
    Acta Med Scand; 1988; 224(5):473-7. PubMed ID: 2974234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Markers of infectivity in carriers of the hepatitis B surface antigen].
    Sekerová Z; Olesová B; Kutálek E
    Cesk Epidemiol Mikrobiol Imunol; 1990 Jun; 39(3):171-7. PubMed ID: 2144478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmission of hepatitis B virus among siblings.
    Kashiwagi S; Hayashi J; Ikematsu H; Nomura H; Kajiyama W; Shingu T; Hayashida K; Kaji M
    Am J Epidemiol; 1984 Oct; 120(4):617-25. PubMed ID: 6475930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal serum IgG subclass pattern in children with Down's syndrome.
    Annerén G; Magnusson CG; Lilja G; Nordvall SL
    Arch Dis Child; 1992 May; 67(5):628-31. PubMed ID: 1534650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus infection among mentally retarded patients in institutions, Okinawa, Japan.
    Hayashi J; Kashiwagi S; Noguchi A; Nakashima K; Ikematsu H; Kajiyama W; Nomura H
    Fukuoka Igaku Zasshi; 1989 Sep; 80(9):436-40. PubMed ID: 2807128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Occurrence of hepatitis B and C among mentally retarded].
    Lunding S; Hansen KS; Krogsgaard K; Rosdahl N; Smith E; Wantzin PS
    Ugeskr Laeger; 1999 Aug; 161(31):4393-6. PubMed ID: 10487103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
    Sanders RC; Lewis D; Dyke T; Alpers MP
    P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T system immune-deficiency in Down's syndrome.
    Levin S; Nir E; Mogilner BM
    Pediatrics; 1975 Jul; 56(1):123-6. PubMed ID: 125869
    [No Abstract]   [Full Text] [Related]  

  • 40. HBsAg and anti-HBs in staff and patients of a psychopaedic hospital.
    Faoagali JL; Young SA
    N Z Med J; 1977 May; 85(588):416-20. PubMed ID: 146172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.